An HIV/AIDS vaccine has proved to be efficient on animals according to researchers at the University of Western Ontario.
"Perhaps we can cure HIV infection. This is our hope," said Dr. Young Kang at the University of Western Ontario.
Clinical trials of the vaccine are expected soon with almost $5i million to be invested by Curocom Co., a company in Korea, into this new medical revelation.
Dr. Yong Kang said, "We have to be careful because we have done the animal, the immune response studies. But that doesn't mean we can repeat exactly the same kind of results in humans."
"We expect that the initial tests will clear the way for this vaccine to be used therapeutically within three years to treat patients suffering from low-level HIV infection," stated Dr. Young Kang who hopes to curb the spread of the HIV virus with this new medical discovery.
He said, "I hope that this research will work for the treatment as well as the prevention of HIV infection.
But we really have to wait until we finish up to the Phase 2 human trials before we can tell whether or not this is going to work or not."
Researchers are currently seeking the U.S. Food and Drug Administration's permission of starting the test on humans.